» Articles » PMID: 37623610

First Reported Case of a Clinically Nonresponsive-to-Itraconazole Isolated from a Skin Infection of a Nonimmunocompromised Patient from Romania

Overview
Journal J Fungi (Basel)
Date 2023 Aug 25
PMID 37623610
Authors
Affiliations
Soon will be listed here.
Abstract

Background: is a melanic fungus capable of causing a wide variety of infections, some of which have lethal potential. It is a ubiquitous fungus and a well-known plant pathogen. Cutaneous infections with most often occur in the extremities of patients who perform conventional agriculture, thus being exposed to occupational hazards leading to the disruption of the skin barrier.

Methods: This paper presents the first case report from Romania of an itraconazole nonresponsive cutaneous alternariosis in a patient without any type of immunosuppression.

Results: After an initial misdiagnosis regarding the etiology of the patient's skin infection, two successive punch biopsies, followed by mycologic examination, lead to the final diagnosis of cutaneous alternariosis. Treatment guided by antifungal susceptibility testing has been instituted, leading to the gradual healing of the patient's skin ulcerations.

Conclusions: The ability of to infect immunocompetent human hosts and to develop resistance to antifungal drugs highlight the importance of correctly diagnosing the etiology of skin ulcerations and instituting appropriate treatment guided by antifungal susceptibility testing whenever the suspicion of a fungal skin infection is plausible.

Citing Articles

The Brief Case: Cutaneous ulceration associated with acalabrutinib treatment.

Luzarraga V, Nourrisson C, Anglade F, Chevenet C, Poirier P, Moniot M J Clin Microbiol. 2025; 63(3):e0158324.

PMID: 40071988 PMC: 11898747. DOI: 10.1128/jcm.01583-24.


Greenhouses represent an important evolutionary niche for .

Yang G, Cui S, Huang W, Wang S, Ma J, Zhang Y Microbiol Spectr. 2024; 12(6):e0039024.

PMID: 38727239 PMC: 11237460. DOI: 10.1128/spectrum.00390-24.


Cutaneous Alternariosis in Immunosuppressed Patients Treated with Photodynamic Therapy and Oral Antifungals, a Synergistic Strategy.

Gil-Pallares P, Gracia-Cazana T, Alvarez-Salafranca M, Gorgojo M, Garcia-Garcia M, Beltran-Rosel A Pharmaceuticals (Basel). 2024; 17(2).

PMID: 38399460 PMC: 10893038. DOI: 10.3390/ph17020245.

References
1.
Altomare G, Capella G, Boneschi V, Viviani M . Effectiveness of terbinafine in cutaneous alternariosis. Br J Dermatol. 2000; 142(4):840-1. DOI: 10.1046/j.1365-2133.2000.03453.x. View

2.
Toc D, Costache C, Botan A, Mihaila R, Colosi I, Buksa S . Mixed Etiology COVID-19 Associated Pulmonary Aspergillosis (CAPA)-A Case Report and Brief Review of the Literature. J Fungi (Basel). 2021; 7(10). PMC: 8540353. DOI: 10.3390/jof7100877. View

3.
Chong W, Neu K . Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review. J Hosp Infect. 2021; 113:115-129. PMC: 8057923. DOI: 10.1016/j.jhin.2021.04.012. View

4.
Chen Z, Jiang Y, Wang D, Zheng M, Liu X, Yuan C . Enhancement in serum (1-3)-β-D-glucan level by cutaneous alternariosis: A case report and literature review. Microb Pathog. 2020; 150:104703. DOI: 10.1016/j.micpath.2020.104703. View

5.
Passero L, Cavallone I, Belda Jr W . Reviewing the Etiologic Agents, Microbe-Host Relationship, Immune Response, Diagnosis, and Treatment in Chromoblastomycosis. J Immunol Res. 2021; 2021:9742832. PMC: 8575639. DOI: 10.1155/2021/9742832. View